Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday. The ...

Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...

Fifty years ago, 20 of the world's brightest people tried to predict life in 2024. They got an awful lot wrong.

Indian drugmakers are preparing for the launch of copycat weight-loss drugs as the world moves towards the patent expiry of ...

Moderation and self-control used to serve as WeightWatchers' main talking points, but the company has since transitioned to ...

Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...

Read More Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday ...